Sonoma Pharmaceuticals (SNOA) Invested Capital (2011 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Invested Capital of $222000.0 for Q1 2026, up 0.91% year-over-year from $220000.0 in Q1 2025, and up 296.43% quarter-over-quarter from $56000.0 in Q3 2025.
Sonoma Pharmaceuticals (SNOA) Invested Capital (2011 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Invested Capital history runs 16 years deep, the most recent figure standing at $222000.0 for Q1 2026.
- In Q1 2026, Invested Capital rose 0.91% year-over-year to $222000.0; the TTM figure through Mar 2026 stood at $417000.0 (down 17.59% YoY), while the FY2026 annual figure was $222000.0, up 0.91% from the prior year.
- Invested Capital for Q1 2026 stood at $222000.0, up from $56000.0 in the prior quarter.
- The five-year high for Invested Capital was $688000.0 in Q1 2022, with the low at $44000.0 in Q4 2023.
- The 5-year median for Invested Capital is $221000.0 (2025), against an average of $255000.0.
- Peak annual rise in Invested Capital reached 15.44% in 2022, while the deepest fall reached 64.96% in 2022.
- Sonoma Pharmaceuticals' Invested Capital stood at $229000.0 in 2022, then tumbled by 80.79% to $44000.0 in 2023, then jumped by 86.36% to $82000.0 in 2024, then tumbled by 31.71% to $56000.0 in 2025, then jumped by 296.43% to $222000.0 in 2026.
- Business Quant data shows SNOA's Invested Capital at $222000.0 in Q1 2026, $56000.0 in Q3 2025, and $139000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 630.00 Mn |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | 140,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 140,000.00 |
| Mar 31, 2026 | 222,000.00 |
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 220,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 204,000.00 |
| Mar 31, 2024 | 323,000.00 |
| Dec 31, 2023 | 44,000.00 |
| Sep 30, 2023 | 172,000.00 |
| Jun 30, 2023 | 301,000.00 |
| Mar 31, 2023 | 431,000.00 |
| Sep 30, 2022 | 229,000.00 |
| Jun 30, 2022 | 459,000.00 |
| Mar 31, 2022 | 688,000.00 |
| Dec 31, 2021 | 587,000.00 |
| Sep 30, 2021 | 587,000.00 |
| Jun 30, 2021 | 1.31 Mn |
| Mar 31, 2021 | 596,000.00 |
| Sep 30, 2020 | 49,000.00 |